ECSP003522A - ACIDS 3- PROPYLGAMMA- MONO- AND AMINOBUTIRIC, DISSTITUTED - Google Patents

ACIDS 3- PROPYLGAMMA- MONO- AND AMINOBUTIRIC, DISSTITUTED

Info

Publication number
ECSP003522A
ECSP003522A ECSP003522A ECSP003522A EC SP003522 A ECSP003522 A EC SP003522A EC SP003522 A ECSP003522 A EC SP003522A EC SP003522 A ECSP003522 A EC SP003522A
Authority
EC
Ecuador
Prior art keywords
mono
acids
propylgamma
disstituted
aminobutiric
Prior art date
Application number
Other languages
Spanish (es)
Inventor
Justin Stephen Bryans
Andrew John Thorpe
Po-Wai Yuen
Thomas Richard Belliotti
Ihoezo Victor Ekhato
Augustine Tobi Osuma
Robert Michael Schelkun
Lawrence David Wise
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to ECSP003522 priority Critical patent/ECSP003522A/en
Publication of ECSP003522A publication Critical patent/ECSP003522A/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente invención es una serie de acidos 3-propil gamma aminobutíricos mono- y disustituidos de la fórmula I. Los compuestos son útiles como agentes terapéuticos en el tratamiento de epilepsia, ataques de desmayo hipoquinesia, trastornos craneanos, trastonos neurodegenerativos, depresión, ansiedad, pánico, dolor, trastornos del sueño, IBS y daño gástrico. Los métodos para preparar los compuestos y los productos intermediso útiles son también parte de la invención.The present invention is a series of mono- and disubstituted 3-propyl gamma aminobutyric acids of formula I. The compounds are useful as therapeutic agents in the treatment of epilepsy, fainting attacks, hypokinesia, cranial disorders, neurodegenerative disorders, depression, anxiety, panic, pain, sleep disorders, IBS and gastric damage. Methods for preparing the compounds and useful intermediates are also part of the invention.

ECSP003522 2000-06-09 2000-06-09 ACIDS 3- PROPYLGAMMA- MONO- AND AMINOBUTIRIC, DISSTITUTED ECSP003522A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ECSP003522 ECSP003522A (en) 2000-06-09 2000-06-09 ACIDS 3- PROPYLGAMMA- MONO- AND AMINOBUTIRIC, DISSTITUTED

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ECSP003522 ECSP003522A (en) 2000-06-09 2000-06-09 ACIDS 3- PROPYLGAMMA- MONO- AND AMINOBUTIRIC, DISSTITUTED

Publications (1)

Publication Number Publication Date
ECSP003522A true ECSP003522A (en) 2000-11-24

Family

ID=42041146

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP003522 ECSP003522A (en) 2000-06-09 2000-06-09 ACIDS 3- PROPYLGAMMA- MONO- AND AMINOBUTIRIC, DISSTITUTED

Country Status (1)

Country Link
EC (1) ECSP003522A (en)

Similar Documents

Publication Publication Date Title
BR0011727A (en) 3-propyl gamma-aminobutyric acids mono- and disubstituted
EA199800798A1 (en) NEW MIXED CYCLIC AMINO ACIDS AS PHARMACEUTICAL AGENTS
CU23112A3 (en) BICYCLE AMINO ACIDS AS PHARMACEUTICAL AGENTS
DE60126980D1 (en) THERAPEUTIC AGENTS AND METHODS OF THEIR USE FOR THE TREATMENT OF AMYLOIDOGENIC ILLNESSES
ES2169848T3 (en) NEW CROWNED CYCLINE AMINO ACIDS AS PHARMACEUTICAL AGENTS.
JP7802945B2 (en) Helmet-type magnetic stimulation device
AR048690A1 (en) ESTEREOSELECTIVE BIOCONVERSION OF ALIFATIC DINITRILS IN CYANOCARBOXYL ACIDS
GT200500127A (en) COMPOSITIONS AND METHODS FOR THE TREATMENT OF PREMENSTRUAL DYSPHORIC DISORDER
AR036137A1 (en) NEW SALTS OF ANTI-CONVULSIVE DERIVATIVES
ES2185591T3 (en) AMINO HEREROCICLES USEFUL AS PHARMACEUTICAL AGENTS.
UY26475A1 (en) NOVEL METHOD FOR STEREOSELECTIVE SYNTHESIS OF CYCLIC AMINO ACIDS.
CR7802A (en) PROLINA DERIVATIVES PRESENTING AFFINITY FOR THE ALFA-2-DELTA SUBUNITY OF THE CALCIUM CHANNEL
ECSP003522A (en) ACIDS 3- PROPYLGAMMA- MONO- AND AMINOBUTIRIC, DISSTITUTED
ECSP055583A (en) COMPOUNDS OF 1-PHENYL-2-DIMETHYLAMINE-METHYL-CYCLHEXAN, FOR THE THERAPY OF DEPRESSIVE SYMPTOMATOLOGY, PAIN AND INCONTINENCE.
BR0010961A (en) Compound, pharmaceutical composition, and, methods to treat epilepsy, dizziness attacks, hypokinesis, and cranial disorders, neurodegenerative disorders, depression, anxiety, panic, pain, neuropathological disorders and sleep disorders
MX9207171A (en) PHARMACEUTICAL PREPARATIONS FOR SCHEDULED RELEASE.
RU2007100837A (en) METHOD FOR TREATING ALVEOLAR NERVE NEURITIS, CAUSED BY DISCLOSURE OF FILLING MATERIAL IN THE MANDIBULAR CHANNEL
UY28111A1 (en) NEW ORAL IMMEDIATE RELEASE DOSAGE FORM
KR20210019206A (en) Transcranial Magnetic Stimulation System
Forster et al. Experimental sensory-induced seizures
RU99109669A (en) METHOD FOR TREATING EPILEPSY BY A MAGNETIC FIELD
CN218391888U (en) Red and blue light prostate therapeutic instrument
SU1641336A1 (en) Belt-corset
UY29470A1 (en) USE OF AGOMELATINE FOR THE OBTAINING OF MEDICINES FOR THE TREATMENT OF BIPOLAR DISORDERS
RU15281U1 (en) APPLICATOR ANTI-RADICULITE